139 results
-
List item
Veterinary medicine European public assessment report (EPAR): Convenia
cefovecin (as sodium salt), Dogs, Cats
Date of authorisation: 19/06/2006, Revision: 13, Authorised, Last updated: 08/12/2020Prevotella oralis … Bacteroides spp., Prevotella oralis, haemolytic Streptococci … -
List item
Human medicine European public assessment report (EPAR): Quofenix
delafloxacin meglumine, Skin Diseases, Bacterial
Date of authorisation: 16/12/2019,
, Revision: 2, Authorised, Last updated: 21/12/2020
-
List item
Human medicine European public assessment report (EPAR): Tobi Podhaler
Tobramycin, Cystic Fibrosis, Respiratory Tract Infections
Date of authorisation: 20/07/2011,
, Revision: 17, Authorised, Last updated: 24/02/2021
-
List item
Human medicine European public assessment report (EPAR): Sivextro (updated)
tedizolid phosphate, Soft Tissue Infections, Skin Diseases, Bacterial
Date of authorisation: 23/03/2015, Revision: 15, Authorised, Last updated: 25/03/2021 -
List item
Human medicine European public assessment report (EPAR): Hycamtin
topotecan, Ovarian Neoplasms, Uterine Cervical Neoplasms, Small Cell Lung Carcinoma
Date of authorisation: 12/11/1996, Revision: 32, Authorised, Last updated: 23/02/2021 -
List item
Human medicine European public assessment report (EPAR): Xydalba
dalbavancin hydrochloride, Soft Tissue Infections, Skin Diseases, Bacterial
Date of authorisation: 19/02/2015, Revision: 12, Authorised, Last updated: 22/02/2021 -
List item
National expert: Marco Tuccori, European Medicines Agency (updated)
- Declaration of interests - 79.95 KB | PDF
- Curriculum Vitae - 35.89 KB | PDF
dei nuovi anticoagulanti orali versus gli antagonisti della … -
List item
Human medicine European public assessment report (EPAR): Cubicin (updated)
daptomycin, Gram-Positive Bacterial Infections, Bacteremia, Soft Tissue Infections, Endocarditis, Bacterial
Date of authorisation: 19/01/2006, Revision: 35, Authorised, Last updated: 08/04/2021 -
List item
Human medicine European public assessment report (EPAR): Vargatef
nintedanib, Carcinoma, Non-Small-Cell Lung
Date of authorisation: 21/11/2014, Revision: 14, Authorised, Last updated: 08/03/2021 -
List item
Human medicine European public assessment report (EPAR): Ofev
nintedanib, Idiopathic Pulmonary Fibrosis
Date of authorisation: 14/01/2015,
, Revision: 17, Authorised, Last updated: 25/01/2021
-
List item
Human medicine European public assessment report (EPAR): Duaklir Genuair
aclidinium bromide, formoterol fumarate dihydrate, Pulmonary Disease, Chronic Obstructive
Date of authorisation: 19/11/2014,, Revision: 12, Authorised, Last updated: 26/11/2020
-
List item
Human medicine European public assessment report (EPAR): Zydelig
Idelalisib, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell
Date of authorisation: 18/09/2014,, Revision: 17, Authorised, Last updated: 05/11/2020
-
List item
Human medicine European public assessment report (EPAR): Kiovig
human normal immunoglobulin (IVIg), Purpura, Thrombocytopenic, Idiopathic, Bone Marrow Transplantation, Immunologic Deficiency Syndromes, Guillain-Barre Syndrome, Mucocutaneous Lymph Node Syndrome
Date of authorisation: 18/01/2006, Revision: 24, Authorised, Last updated: 20/12/2019 -
List item
Human medicine European public assessment report (EPAR): Pradaxa (updated)
Dabigatran etexilate mesilate, Arthroplasty, Replacement, Venous Thromboembolism
Date of authorisation: 17/03/2008,
, Revision: 33, Authorised, Last updated: 17/03/2021
-
List item
Human medicine European public assessment report (EPAR): Jinarc
Tolvaptan, Polycystic Kidney, Autosomal Dominant
Date of authorisation: 27/05/2015,, Revision: 14, Authorised, Last updated: 16/04/2020
-
List item
Human medicine European public assessment report (EPAR): Sarclisa
Isatuximab, Multiple Myeloma
Date of authorisation: 30/05/2020,, Authorised, Last updated: 12/06/2020
-
List item
Human medicine European public assessment report (EPAR): Brimica Genuair
formoterol fumarate dihydrate, aclidinium bromide, Pulmonary Disease, Chronic Obstructive
Date of authorisation: 19/11/2014,, Revision: 11, Authorised, Last updated: 29/08/2019
-
List item
Human medicine European public assessment report (EPAR): Dutrebis
lamivudine, raltegravir potassium, HIV Infections
Date of authorisation: 26/03/2015, Withdrawn, Last updated: 27/04/2017 -
List item
Human medicine European public assessment report (EPAR): Rienso
Ferumoxytol, Anemia, Kidney Failure, Chronic
Date of authorisation: 15/06/2012,, Revision: 7, Withdrawn, Last updated: 13/07/2015
-
List item
Human medicine European public assessment report (EPAR): Seffalair Spiromax (new)
fluticasone propionate, salmeterol xinafoate, Asthma
Date of authorisation: 26/03/2021, Authorised, Last updated: 13/04/2021 -
List item
Human medicine European public assessment report (EPAR): BroPair Spiromax (new)
salmeterol xinafoate, fluticasone propionate, Asthma
Date of authorisation: 26/03/2021, Authorised, Last updated: 14/04/2021 -
List item
Herbal medicinal product: Andrographidis paniculatae folium
Andrographis paniculata Nees, Kalmegh, F: Assessment finalised, Last updated: 30/04/2018 -
List item
Referral: Zyrtec
cetirizine, Article 30 referrals
Status: European Commission final decision, opinion/position date: 30/05/2008, EC decision date: 06/10/2008, Last updated: 16/10/2008 -
List item
Referral: Cevazuril
toltrazuril, Article 33
Status: European Commission final decision, opinion/position date: 09/12/2009, EC decision date: 26/03/2010, Last updated: 05/05/2010 -
List item
Referral: Durogesic and associated names
fentanyl, Article 30 referrals
Status: European Commission final decision, opinion/position date: 21/07/2016, EC decision date: 22/09/2016, Last updated: 19/10/2016